“…The pharmacological effects of Chrysanthemum morifolium , including Mottenohoka, are various and include sleep induction [1], protection of brain cells against ischemia [2], toxicity to cancer cells [3], suppression of intercellular adhesion molecule-1 and E-selectin expression [4], protection of neuroblastoma SH-SY5Y cells [5], cardiac protection against ischemia [6], anti-HIV effect [7, 8], and antimutagenicity [9]. Components of Chrysanthemum morifolium that may be associated with these pharmacological effects are luteolin and apigenin [10, 11], acidic polysaccharide [3, 12], dicaffeoylquinic acids [13], chlorogenic acid, 3,5- O -dicaffeoylquinic acid, 3′,4′,5-trihydroxyflavanone 7- O -glucuronide [14], apigenin 7- O - β - d -(4′-caffeoyl)glucuronide and apigenin 7- O - β - d -glucuronide [7], acacetin, apigenin, luteolin and quercetin [9], and acacetin 7- O - β - d -galactopyranoside [8]. …”